COMMUNIQUÉS West-GlobeNewswire

Sana Biotechnology to Present at June 2026 Investor Conferences
27/05/2026
SEATTLE, May 27, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations [...]
Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company’s Strategic Direction and Highly Qualified Nominees
27/05/2026
Clarifies DOMA’s Inaccuracies and the Reality of Pacira’ Efforts to Strengthen its Market Position Urges Stockholders to Vote “ FOR ” the Election of Pacira’s Highly Qualified Nominees on the BLUE Proxy Card Today [...]
Supernus Pharmaceuticals to Participate in June Investor Conferences
27/05/2026
ROCKVILLE, Md., May 27, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
27/05/2026
MINNEAPOLIS, May 27, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York
27/05/2026
SAN DIEGO, May 27, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today announced that chief executive officer Kristin Yarema, Ph.D., will present at the Jefferies Global Healthcare [...]
Gala Health: High-Quality Compounded GLP-1 Weight Loss & Hormone Therapy HRT Support
27/05/2026
Compounded Tirzepatide, Semaglutide, and Hormone Replacement Therapy Through Gala GLP-1: Licensed Provider Telehealth Plans Starting at $149/Month for 2026 Wilmington, Delaware, May 27, 2026 (GLOBE NEWSWIRE) -- [...]
Assemblée Générale Mixte du 27 mai 2026
27/05/2026
Communiqué de presse - Approbation de l’ensemble des résolutions proposées par le Conseil d’administration - Paris – Le 27 mai 2026 - L’Assemblée Générale Mixte des actionnaires d’EUROAPI s’est réunie le 27 mai 2026 à [...]
Combined General Meeting of May 27, 2026
27/05/2026
Press Release - Approval of all resolutions submitted by the Board of Directors - Paris – May 27, 2026 – The Combined General Meeting of EUROAPI Shareholders was held on May 27, 2026 in Paris, under the chairmanship of [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 21 - 2026
27/05/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 18 mai au 22 mai 202 6 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 21 - 2026
27/05/2026
Aggregated presentation by day and by market Purchases of own shares from May 18th to May 22nd 2026 Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total [...]
Vigortrix Male Enhancement Claims Evaluated: The Horse Gelatin Trick for Men's Stallion-Like Vigor Boost Performance Support
27/05/2026
VigorTrix Ingredients Explained: L-Citrulline, Maca Root, Pine Bark, Velvet Bean, and Saffron in a Men's Vitality and Stamina Supplement With a 60-Day Money-Back Guarantee Aurora, CO, May 27, 2026 (GLOBE NEWSWIRE) -- [...]
CDT Announces Canadian Patent for AZD5904 in Male Infertility
27/05/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 27, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announces that the patent covering the use of AZD5904 in male infertility has [...]
New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia
27/05/2026
DUBLIN and BRIDGEWATER, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (Amarin), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today announced new [...]
Cogent Biosciences Announces Participation in the 2026 Jefferies Global Healthcare Conference
27/05/2026
WALTHAM, Mass. and BOULDER, Colo., May 27, 2026 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today [...]
Callio Therapeutics to Present Phase 1 Trial Design of CLIO-8221, Novel Dual-Payload ADC, at ASCO 2026
27/05/2026
SEATTLE and SINGAPORE, May 27, 2026 (GLOBE NEWSWIRE) -- Callio Therapeutics, a biotherapeutics company advancing dual-payload antibody-drug conjugates (ADCs) with a targeted, multi-mechanism approach to cancer treatment [...]
Join BioVie’s Exclusive Live Investor Webinar and Q and A Session on June 2
27/05/2026
CARSON CITY, Nev., May 27, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, [...]
Pacira BioSciences Reports Real-World Study Showing EXPAREL® Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty
27/05/2026
Findings presented at ISPOR 2026 showed lower opioid consumption, reduced healthcare costs, and fewer opioid-related adverse events associated with EXPAREL use BRISBANE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- Pacira [...]
Avalyn to Participate in the Jefferies Global Healthcare Conference
27/05/2026
BOSTON, May 27, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (Nasdaq: AVLN), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory [...]
Annexon to Participate in Upcoming June Investor Conferences
27/05/2026
BRISBANE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that [...]

Pages